Concentra Group Holdings Parent, Inc. - 10-Q Summary (Q2 2026)
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2026. Concentra Group Holdings Parent, Inc. is the largest provider of occupational health services in the United States by number of locations. As of the reporting date, the Company operated 633 stand-alone occupational health centers in 41 states and 415 onsite health clinics at employer worksites in 44 states. The Company operates as a single reportable segment offering workers' compensation, employer services, and consumer health services.
Key Financial Metrics
| Metric | Q2 2026 (3 Months) | Q2 2025 (3 Months) | YTD 2026 (6 Months) | YTD 2025 (6 Months) |
|---|---|---|---|---|
| Revenue | $606.0 million | $550.8 million | $1,175.6 million | $1,051.5 million |
| Net Income (Company) | $65.3 million | $44.6 million | $115.8 million | $83.5 million |
| Diluted EPS | $0.51 | $0.35 | $0.90 | $0.65 |
| Adjusted EBITDA | $140.9 million | $115.0 million | $261.6 million | $217.7 million |
| Operating Cash Flow (YTD) | $156.2 million (2026) vs $100.1 million (2025) | |||
| Cash & Equivalents | $158.0 million (as of June 30, 2026) | |||
| Total Debt (Carrying Value) | $1,573.6 million (as of June 30, 2026) | |||
| Leverage Ratio | 2.99x (as of June 30, 2026) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 10.0% in Q2 2026 and 11.8% YTD compared to 2025. Growth was driven by organic increases in patient visits (2.6% in Q2, 4.5% YTD) and revenue per visit (4.6% in Q2, 3.9% YTD), alongside contributions from the acquisition of Pivot Onsite Innovations (completed June 2025).
- Profitability Expansion: Operating margin improved to 19.0% in Q2 2026 from 16.3% in Q2 2025. Net income attributable to the Company grew 46.5% in Q2 and 38.7% YTD.
- Cost Efficiency: Cost of services as a percentage of revenue decreased to 68.3% in Q2 2026 from 70.7% in Q2 2025, attributed to staffing efficiencies and the elimination of one-time acquisition expenses incurred in the prior year.
- Interest Expense: Interest expense decreased to $25.7 million in Q2 2026 from $28.2 million in Q2 2025, primarily due to the amortization of the term loan and the repayment of $85 million in revolving credit facility borrowings by October 2025.
Guidance, Outlook, and Risks
Capital Allocation: The Company continues to execute a $100 million share repurchase program authorized in November 2025. As of June 30, 2026, $54.1 million remains available. The Board declared a quarterly cash dividend of $0.0625 per share, payable in August 2026.
Liquidity: The Company maintains strong liquidity with $158.0 million in cash and $430.2 million of availability under its Revolving Credit Facility. The leverage ratio of 2.99x is well below the 6.5x covenant maximum.
Risks and Contingencies:
- Litigation: The Company is involved in a California whistleblower lawsuit regarding physical therapy referral guidelines and billing practices. Additionally, a DOJ investigation into physical therapy billing (originally targeting the former parent, Select) continues, with the Company cooperating fully.
- Data Breach: A 2023 data breach at a third-party vendor (Perry Johnson & Associates) affecting nearly four million patients has resulted in consolidated class action litigation. Management does not currently believe this will have a material financial impact.
- Regulatory: Risks include changes in state workers' compensation fee schedules, reimbursement rates, and evolving data privacy regulations.
Investor Verification Checklist
- Acquisition Integration: Verify the ongoing financial contribution and synergy realization from the Pivot Onsite Innovations acquisition (240+ onsite clinics).
- Reimbursement Trends: Monitor state-specific fee schedule changes for workers' compensation and employer services to validate the sustainability of the 4.6% increase in revenue per visit.
- Litigation Exposure: Track developments in the California Insurance Fraud Prevention Act lawsuit and the DOJ physical therapy billing investigation for potential material liabilities.
- Debt Servicing: Confirm the impact of interest rate fluctuations on the unhedged portion of the Term Loan ($638.1 million) despite existing swap and collar hedges.
- Share Repurchase Pace: Assess the remaining $54.1 million authorization and the Company's commitment to returning capital versus funding future growth or acquisitions.